AGP Executive Report
Last update: 11 hours agoPharma Manufacturing Investment: Bayer will build a $2.2bn modular drug manufacturing campus in New Albany, Ohio, with drug-substance capacity starting in 2031 and finished-dose modules following in 2034, targeting oncology, cardiovascular and renal medicines. Industrial Policy & Trade: The UK is reviewing whether to impose tariffs on Chinese car imports to align with EU “Made in Europe” rules, a move that could trigger retaliation and requires a WTO process. Energy Storage for Telecom: Cygni Energy and Indus Towers plan to explore BESS sourcing and set up up to 1.5 GWh of battery manufacturing capacity for telecom infrastructure in India. Solar Supply Chain: Waaree Energies commissioned 1.1GW PV inverter nameplate capacity and is expanding across modules and upstream inputs, while a study highlights how digital twins could help China’s PV firms fight “involution” and price wars. Manufacturing Output Watch: India’s industrial production rose 8% in August; textiles grew 13.1% YoY while wearing apparel fell 7.4%. Defense Manufacturing: Ireland ordered Thales Ground Master radars, with deliveries starting in 2027, and Diehl will adapt IRIS-T SLM for Germany’s F125 frigates. Regional Export Mix: Cambodia’s non-garment manufacturing exports surged 37.3% YoY in the first eight months, offsetting weaker services.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
